DSpace Repository

Use of medicinal plants in patients with chronic kidney disease from Peru

Show simple item record

dc.contributor.author Herrera-Añazco, Percy
dc.contributor.author Taype-Rondan, Alvaro
dc.contributor.author Ortiz, Pedro J.
dc.contributor.author Málaga Rodríguez, Germán Javier
dc.contributor.author Muñoz del Carpio-Toia, Agueda
dc.contributor.author Alvarez-Valdivia, M.G.
dc.contributor.author Juárez- Huanca, C.
dc.contributor.author Ciudad- Fernandez, L.
dc.contributor.author Bruner- Meléndez, R.
dc.contributor.author Samaniego- Mojica, W.
dc.contributor.author Perez- Rafael, E.
dc.date.accessioned 2022-03-24T21:47:43Z
dc.date.available 2022-03-24T21:47:43Z
dc.date.issued 2019
dc.identifier.uri https://hdl.handle.net/20.500.12866/11510
dc.description.abstract Objective: To describe the use of medicinal plants in patients with chronic kidney disease (CKD) in public healthcare centers in Peru. Methods: A cross-sectional study was conducted in patients with CKD in healthcare centers of three Peruvian regions: Lima, Arequipa, and Ucayali. A structured questionnaire which included socio-demographic data, medical antecedents and characteristics of the use of medicinal plants was used. Prevalence ratios (PR) and 95 % confidence intervals (95% CI) were calculated using crude Poisson regressions with robust variances. Results: A total of 599 patients with CKD were evaluated, of which 300 (50.1%) reported the use of medicinal plants (160 [30.3%] used these plants for CKD), 379 reported that medicinal plants were not harmful, while 166 (27.8%) stopped using allopathic medicine to use medicinal plants only. In the adjusted analysis, the frequency of the use of medicinal plants for CKD was similar between Lima and Arequipa but was lower in Ucayali than in Lima (PR: 0.32, 95% CI: 0.14 – 0.76). In addition, a higher frequency of the use of medicinal plants for CKD was observed in patients with more advanced stages of CKD (PR: 1.55, 95% CI: 1.06–2.26) and in patients who were aware they had CKD (PR: 2.79 95% CI: 1.39–5.63). Conclusions: Half of the patients used medicinal plants and about one-third used it for CKD. This use was lower in Ucayali and higher in both the patients who knew they had CKD and those with more advanced stages of the disease. Given these results, physicians should ask and inform regarding medicinal plants consumption to their CKD patients. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Complementary Therapies in Medicine
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Medicinal plants en_US
dc.subject Chronic kidney disease en_US
dc.subject Healthcare centers en_US
dc.subject Medical care en_US
dc.subject Peru en_US
dc.title Use of medicinal plants in patients with chronic kidney disease from Peru en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.ctim.2019.102215
dc.relation.issn 1873-6963


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics